Daré Bioscience, Inc. (DARE)
0.7405
-0.07
(-8.29%)
USD |
NASDAQ |
Sep 24, 16:00
0.7421
0.00 (0.00%)
After-Hours: 07:09
Daré Bioscience Gross Profit (Annual) : -1.417M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.417M |
| December 31, 2024 | -0.5035M |
| December 31, 2023 | 2.770M |
| December 31, 2022 | 9.952M |
| December 31, 2021 | -0.0264M |
| December 31, 2020 | -0.0432M |
| December 31, 2019 | -0.0111M |
| December 31, 2018 | -0.0024M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | -0.192M |
| December 31, 2014 | 0.00 |
| December 31, 2013 | -0.191M |
| December 31, 2012 | 0.279M |
| December 31, 2011 | -0.058M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Nektar Therapeutics | 54.21M |
| Elite Pharmaceuticals, Inc. | 73.48M |
| Eton Pharmaceuticals, Inc. | 42.74M |
| ANI Pharmaceuticals, Inc. | 450.64M |
| Corcept Therapeutics, Inc. | 748.43M |